These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12848158)

  • 21. The role of nuclear medicine in the management of Graves' disease.
    Freitas JE
    Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estimation of effective half life of 131I in radioiodine therapy for Graves' disease using a single radioiodine uptake measurement].
    Watanabe M; Ito K; Mimura T; Ishikawa N; Ino E; Saitoh T; Tsuji H; Tsuchiya T
    Kaku Igaku; 1993 Sep; 30(9):1055-62. PubMed ID: 8230826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculating the incalculable. Optimal radioiodine dose in Graves' hyperthyroidism.
    Hegedüs L; Bonnema SJ
    Endocrine; 2017 Apr; 56(1):222-223. PubMed ID: 28188478
    [No Abstract]   [Full Text] [Related]  

  • 25. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioiodine therapy for Graves' disease: problems and new developments].
    Reiners C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():55-62. PubMed ID: 15255314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [F-qi-FDG PET of the thyroid gland in Graves' disease].
    Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
    Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?
    Kalinyak JE; McDougall IR
    J Clin Endocrinol Metab; 2003 Mar; 88(3):975-7. PubMed ID: 12629070
    [No Abstract]   [Full Text] [Related]  

  • 29. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

  • 30. [Radioiodine treatment of hyperthyroid states].
    Leisner B
    Dtsch Med Wochenschr; 1991 Mar; 116(11):423-5. PubMed ID: 2001652
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the effects of radioiodine therapy on Graves' ophthalmopthy.
    Bartalena L; Marcocci C; Pinchera A
    Thyroid; 1998 Jun; 8(6):533-4. PubMed ID: 9669292
    [No Abstract]   [Full Text] [Related]  

  • 33. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioiodine therapy and Graves' ophthalmopathy.
    Spitzweg C; Rossmüller B; Heufelder AE
    Thyroid; 1998 Dec; 8(12):1193. PubMed ID: 9920377
    [No Abstract]   [Full Text] [Related]  

  • 35. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible method using baseline hormonal levels to prescribe the appropriate oral therapeutic radioiodine dosage for Graves' disease.
    Nakajo M; Tsuchimochi S; Jinguji M; Tanabe H; Umanodan T; Nakabeppu Y
    Ann Nucl Med; 2007 Oct; 21(8):471-6. PubMed ID: 17952556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radioiodine tretment of Graves' disease (author's transl)].
    Konishi J; Kasagi K; Iida Y; Mori T; Torizuka K
    Horumon To Rinsho; 1979 Nov; 27(11):1239-43. PubMed ID: 583264
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of Basedow's disease in early pregnancy with iodine radioisotopes].
    Gavallér I
    Orv Hetil; 1974 May; 115(20):1169-71. PubMed ID: 4406530
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guidelines for radioiodine therapy (RIT) in benign thyroid diseases].
    Dietlein M; Dressler J; Joseph K; Leisner B; Moser E; Reiners C; Schicha H; Schneider P; Schober O
    Nuklearmedizin; 1999; 38(6A):219-20. PubMed ID: 10510811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.